Journavx
Payments companies reported to CMS as associated with Journavx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Journavx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Journavx
These are the largest totals companies reported as associated with Journavx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Vinod Dasa | Kenner, LA | Orthopaedic Surgery | $91,723.19 |
| Scott Sigman | North Chelmsford, MA | Orthopaedic Surgery | $90,589.35 |
| Nirav Amin | Placentia, CA | Orthopaedic Surgery | $70,918.58 |
| Raymond Hwang | Chestnut Hill, MA | Orthopaedic Surgery of The Spine | $60,272.25 |
| Michael Bottros | Los Angeles, CA | Anesthesiology | $55,706.24 |
| Kevin Plancher | New York, NY | Orthopaedic Surgery | $47,595.51 |
| Andrew Noble | Palm Beach Gardens, FL | Adult Reconstructive Orthopaedic Surgery | $46,550.85 |
| Anthony Gonzalez | Miami, FL | Surgery | $44,392.59 |
| Reed Levine | Pasadena, CA | Pain Medicine | $43,704.58 |
| Jacob Hutchins | Minneapolis, MN | Anesthesiology | $42,396.27 |
Prescribed Journavx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.